Stockscreener 앱 받기
9.54
0.63%
0.06
전일 마감가:
$9.48
열려 있는:
$9.48
하루 거래량:
171.18K
Relative Volume:
0.12
시가총액:
$1.29B
수익:
$3.26B
순이익/손실:
$-214.34M
주가수익비율:
-5.7818
EPS:
-1.65
순현금흐름:
$229.32M
1주 성능:
+4.49%
1개월 성능:
+14.94%
6개월 성능:
-7.02%
1년 성능:
-16.28%
1일 변동 폭
$9.385
$9.55
1주일 범위
$8.80
$9.64
52주 변동 폭
$7.105
$11.90
Adapthealth Corp Stock (AHCO) Company Profile
명칭
Adapthealth Corp
전화
610-424-4515
주소
555 EAST NORTH LANE, CONSHOHOCKEN, PA
AHCO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AHCO
Adapthealth Corp
|
9.54 | 1.21B | 3.26B | -214.34M | 229.32M | -1.65 |
|
ABT
Abbott Laboratories
|
123.87 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.69 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.00 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.24 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.88 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-01-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-11-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-05-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-05-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-05-09 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-09-27 | 개시 | SVB Leerink | Outperform |
| 2021-07-14 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-04-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2021-03-18 | 개시 | Truist | Buy |
| 2021-01-26 | 개시 | BofA Securities | Buy |
| 2020-12-10 | 개시 | UBS | Buy |
| 2020-08-10 | 개시 | Canaccord Genuity | Buy |
| 2020-07-01 | 재개 | SVB Leerink | Outperform |
| 2020-06-09 | 개시 | RBC Capital Mkts | Outperform |
| 2020-01-31 | 개시 | Stifel | Buy |
| 2020-01-07 | 개시 | Jefferies | Buy |
| 2019-12-11 | 개시 | SVB Leerink | Outperform |
| 2019-12-10 | 개시 | Deutsche Bank | Buy |
모두보기
Adapthealth Corp 주식(AHCO)의 최신 뉴스
Insufficient Growth At AdaptHealth Corp. (NASDAQ:AHCO) Hampers Share Price - simplywall.st
AdaptHealth to Announce Q2 2025 Financial Results on August 5 - MSN
What drives AdaptHealth Corp. stock priceRobust investment performance - jammulinksnews.com
What analysts say about AdaptHealth Corp. stockConsistent triple returns - jammulinksnews.com
Is AdaptHealth Corp. a good long term investmentHigh-margin investment plays - jammulinksnews.com
Briefly: AdaptHealth to Discuss Financial Results; AARC Seeking Zenith Award Nominees - HME Business
AdaptHealth Corp. Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
Truist Financial Remains Bullish on AdaptHealth (AHCO) - MSN
4 'Strong Buy' Stocks Under $10 with Up to 55% Upside - Investing.com
AdaptHealth Corp. Announces Second Quarter 2025 Earnings Release Date and Conference Call - Business Wire
(AHCO) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Is the Options Market Predicting a Spike in AdaptHealth Stock? - Nasdaq
AdaptHealth Sells Infusion Assets, Advances Debt Reduction Strategy - MSN
AdaptHealth’s SWOT analysis: stock resilience amid market challenges - Investing.com
AdaptHealth Corp.: Divesting for Survival and Shareholder Value - AInvest
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on - GlobeNewswire
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. ... - Bluefield Daily Telegraph
AdaptHealth stock maintains Buy rating at Truist after infusion asset sale - Investing.com Canada
AdaptHealth Latest Strategic Move: $65M Debt Slash from Healthcare Asset Sale Signals Major Restructuring - Stock Titan
AdaptHealth Corp.(NasdaqCM:AHCO) dropped from Russell Small Cap Comp Growth Index - MarketScreener
AdaptHealth Completes Infusion Asset Sale; 2025 Outlook Updated - MarketScreener
Truist reiterates buy rating on AdaptHealth stock citing market position - Investing.com
Is AdaptHealth Corp. overvalued or undervalued? - MarketsMojo
AdaptHealth Approves Key Proposals at Annual Meeting - TipRanks
AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business - Yahoo Finance
AdaptHealth Q1 Net Loss Widens as Revenue Drops - MarketScreener
Two Sigma Investments LP Trims Holdings in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
Nuveen Asset Management LLC Raises Stake in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care - Seeking Alpha
Where are the Opportunities in (AHCO) - news.stocktradersdaily.com
BNP Paribas Financial Markets Takes $229,000 Position in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Stock Holdings in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
Deutsche Bank AG Grows Stock Position in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
AdaptHealth Corp. (NASDAQ:AHCO) Shares Bought by Janus Henderson Group PLC - Defense World
Ameriprise Financial Inc. Buys 65,606 Shares of AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
Winners And Losers Of Q3: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks - The Globe and Mail
D. E. Shaw & Co. Inc. Sells 301,092 Shares of AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
Deadline Approaching for Receiving Share of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (AHCO) RecoveryContact Levi & Korsinsky, LLP for Further Details - ACCESS Newswire
AdaptHealth to Join RBCCM Global Healthcare Conference with Fireside Chat - MSN
Adapthealth at RBC Conference: Strategic Moves and Challenges - Investing.com Australia
Adapthealth revises 2025 revenue guidance to $3.18B-$3.32B amid asset sales and operational improvements - MSN
AdaptHealth Reports First Quarter 2025 Financial Results, Updates Guidance - MSN
Adapthealth Corp (AHCO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adapthealth Corp 주식 (AHCO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Clemens Jason A | Chief Financial Officer |
Dec 10 '24 |
Sale |
9.35 |
35,000 |
327,250 |
420,719 |
0.43%
0.53%
자본화:
|
볼륨(24시간):